Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-01

FDA Approved: CANASA — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approves a supplemental application for CANASA (mesalamine) by Allergan, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CANASA (Mesalamine)

Snippet

SUPPL AP for CANASA (MESALAMINE)